Changes in Utilization and Discard of Hepatitis C Infected Donor Livers in the Recent Era

The impact of interferon (IFN)-free direct acting antiviral (DAA) hepatitis C virus treatments on utilization and outcomes associated with HCV+ deceased-donor liver transplantation (DDLT) is largely unknown. Using SRTR, we identified 25,566 HCV+ DDLT recipients from 2005 to 2015, and compared practi...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Am J Transplant
Glavni autori: Bowring, Mary G, Kucirka, Lauren M, Massie, Allan B, Luo, Xun, Cameron, Andrew, Sulkowski, Mark, Rakestraw, Katie, Gurakar, Ahmet, Kuo, Irene, Segev, Dorry L, Durand, Christine M
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5266634/
https://ncbi.nlm.nih.gov/pubmed/27456927
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.13976
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items